Crypto airdrop to support SENS Research Foundation

Latest articles

Ovarian aging – it’s time to menopause for thought

It's World Menopause Day – time to focus on the future of ovarian longevity, not dwell in the present. World Menopause Day is held every...

At-home blood test powers personalised longevity advice

AgeRate develops proprietary DNA methylation clock and mobile app solution to offer users personalised longevity support. Canadian startup AgeRate is aiming to shake up the...

Researchers find warning signs for dementia in the blood

Levels of certain microRNAs indicate risk for cognitive decline. Researchers at the DZNE and the University Medical Center Göttingen (UMG) have identified molecules in the...

VIDEO: The Science of Ovarian Longevity

Instead of papering over the cracks of declining fertility and the effects of menopause, what else can we do to help the longevity of...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

Ovarian aging – it’s time to menopause for thought

It's World Menopause Day – time to focus on the future of ovarian longevity, not dwell in the present. World Menopause Day is held every...

At-home blood test powers personalised longevity advice

AgeRate develops proprietary DNA methylation clock and mobile app solution to offer users personalised longevity support. Canadian startup AgeRate is aiming to shake up the...

Researchers find warning signs for dementia in the blood

Levels of certain microRNAs indicate risk for cognitive decline. Researchers at the DZNE and the University Medical Center Göttingen (UMG) have identified molecules in the...

Click the globe for translations.

New crypto currency Pulse set to boost antiaging research.

Cryptocurrency HEX founder Richard Heart is creating a new currency, Pulse. Prior to the launch of this new cryptocurrency, Richard is doing an Airdrop – giving away some Pulse – and he’s doing it to support the SENS Research Foundation (SRF).

Longevity.Technology: SENS Research Foundation works to develop, promote and ensure widespread access to therapies that cure and prevent the diseases and disabilities of aging by comprehensively repairing the damage that builds up in our bodies over time – so far, so denotable. The worlds of crypto and longevity have been moving inexorably together; we have seen crypto finance experts developing an interest in antiaging and a longevity-focused crypto platform launch a token auction.

Now Richard Heart, the man behind HEX, a high-interest blockchain certificate of deposit (CD), which lets users stake their tokens in return for interest, wants to do his part.

Heart is asking that people “sacrifice”, or make a donation, to SRF during the sacrifice phase. Those that make a donation to SRF will be entered into the Airdrop and a given chance to earn Pulse when it launches, free of charge. SRF stress that interested parties should NOT make any donation until they are notified by SRF that the sacrifice phase has begun; however, if you are interested, please do notify SRF of your intention to donate.

audrey
Aubrey de Grey, Chief Science Officer and Co-founder, SRF

Donations can be in currency: crypto, credit, stock or fiat. SRF will liquidate it for its USD value and communicate that donation value to Heart, along with the Ethereum wallet address provided. All the details for the airdrop can be found here.

With rumours of over $7m committed by email so far, Longevity.Technology reached out to Richard Heart for his take on what the donations could mean for antiaging research.

“Cancer and heart disease kill 80% of us,” Heart told us. “Curing either only gets us 3 extra years of life, because the next thing kills us. We can do better than curing either by focusing on repairing the damage early! Every year billions of dollars goes into research that at the very best maxes out at 3 years of value. While research that could get us more than 3 years of healthy life goes unfunded!

“We have a chance for outsized returns because while other research has billions put into it, rejuvenation research doesn’t yet – your dollars can have more impact. Those interested in the fork should visit t.me/PulseChainCom.”

Find out more about the Pulse Chain Airdrop for the SENS Research Foundation.

Image courtesy of Richard Heart and Erin Ashford
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

$70m collaboration to redefine aging research

Astera Institute and Buck Institute announce $70 million collaboration to redefine the field of research on aging. The Buck Institute for Research on Aging and...

Rejuveron leads €15.7m series B in Rejuvenate Biomed

Investment in Rejuvenate Biomed set to accelerate clinical development of its sarcopenia treatment for healthy aging. Rejuveron Life Sciences, a Zürich-based biotechnology company developing therapies...

Maximon launches 100 million Longevity Co-Investment Fund

The Longevity Co-Investment Fund finances longevity-focussed start-up companies launched by company-builder Maximon. Switzerland-based Maximon has announced the launch of its Longevity Co-Investment Fund (LCIF),...

NOVOS – from stealth to oversubscription and beyond

NOVOS is dreaming big to improve health, quality of life and lifespan all at the same time. Last week we covered NOVOS' $3.15 million pre-seed...

Longevity start-up NOVOS closes $3.15m financing round

Successful round for NOVOS sees longevity supplement company raise $3.15 million pre-seed to further its aim to extend healthy human lifespan with science-based supplements. NOVOS,...